HIV Virus Issues

While none of these drugs is a cure for acquired immune deficiency syndrome, they may delay the onset of symptoms. According to Bristol-Myers Squibb, the manufacturer of Stavudine, this drug forget be shipped to sweepingrs at a wholesale cost of $6.22 daily per patient (FDA, 1994, p. A2). As disap degreeing as this is to those afflicted with the disease and to its future potential victims, these four drugs wait to be the best that medical science has to offer to date.

wellness check science, in its search for an AIDS cure, is constantly losing ground against the virus. some(prenominal) of the successes that researchers check had on computer screens, in scrutiny tubes, and in monkeys have proved difficult to repeat in humans. in that location was great hope for AZT when it was first developed, but test results released in Europe in 1993 indicated that it may not obtain a significant difference--though among scientists this remains a controversial point (Sullivan, 1994, p. 59). For example, this European test comp ard the long-term prognosis of patients with AIDS hard-boiled and not treated with Zidovudine. The objective was to determine the association amongst elapsed time since starting zidovudine and survival in patients with AIDS. The results among patients who did not receive zidovudine showed that their death rate was nearly constant for the first five years after AIDS diagnosis. For patients treated with AZT,

McCarthy, M. (1994, April 9). Injecting drugs and AIDS. Lancet, p. 911.

Business and childbed orchestrateers are also assessing the impact AIDS will have on the economy and how they can take the lead in what must be a world-wide effort to prevent, treat, and in conclusion cure this disease. For example, I. MaCallister Booth, chairman, president, and chief executive officer of Polaroid Corporation, stated in his speech at the 1993 Business and Labor Conference on AIDS that AIDS is a global development issue, a challenge for all society, not just a health issue. He cited as an example the fact that nearly 1 out of every 10 people in Uganda are infected with HIV.

With once able-bodied men and women now ptyalize or dying, the work force of Uganda has declined sharply in size and productivity--depressing such vital sources of foreign earnings as cocoa exports. There are simply not enough salubrious people in Uganda to grow and process that crop. In nigh Zambia, an estimated one out of five workers in the vital hair industry carries HIV, most of whom will be dead by the end of the 1990s. Furthermore, people in other African, South and cardinal American, and Asian countries are similarly affected (Booth, 1994, p. 343).

Hall, S.S. (1994, March 25). IL-12 holds insure against cancer, glimmer of AIDS hope. Science, pp. 1685-1686.

Blacks are less likely. (1994, March 17). surround Street Journal, p. A1.

New research has indicated that there is a spirited incidence of anal cancer among AIDS patients. Until now, the only cancers that have been strongly associated with AIDS are Kaposi's sarcoma and non-Hodgkin lymphoma. However, because homosexual men were at an increase risk of anal cancer even earlier the AIDS epidemic, researchers cannot say how much of the increased risk is ascribable to HIV infection. Nevertheless, clinicians should be aware that AIDS patients have an increased risk of anal cancer (Melbye & et al., 1994, p. 636).

after starting therapy (Lund
Order your essay at Orderessay and get a 100% original and high-quality custom paper within the required time frame.